BeiGene to Present at the RBC Capital Markets Global Healthcare Conference
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will participate in the RBC Capital Markets Global Healthcare Conference on May 20, 2025, with a fireside chat at 10 a.m. EDT.
The live webcast of this event can be accessed from the investors section of the Company’s website at http://ir.beigene.com/, https://hkexir.beigene.com/, https://sseir.beigene.com/. An archived replay will be available for 1 year following the event.
About BeiGene
BeiGene, which will change its name to BeOne Medicines, is a global oncology company that is discovering and developing innovative treatments that are more accessible and affordable to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 11,000 colleagues spans six continents. To learn more about BeiGene, please visit www.beigene.com.
Forward-Looking Statements
This presentation may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding BeiGene's plans, commitments, aspirations and goals related to BeiGene’s medicines and drug candidates. Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors which are discussed in the section entitled “Risk Factors” in BeiGene’s most recent periodic report filed with the U.S. Securities and Exchange Commission (“SEC”) as well as discussions of potential risks, uncertainties, and other important factors in BeiGene's subsequent filings with the SEC. All information in this presentation is as of the date presented, and BeiGene undertakes no duty to update such information unless required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250513199895/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies12.6.2025 17:00:00 CEST | Press release
The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyze an ambitious future phase to develop a cancer plasticity atlas encompassing hundreds of millions of cells. Utilizing novel organoid perturbation and Artificial Intelligence (AI) platforms, the aim is to create a comprehensive dataset to fuel foundational drug discovery models and cancer research. Dr. Mathew Garnett, Group Leader at the Sanger Institute, and Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Associate Faculty at the Sanger Institute, will be the principal investigators in the collaboration. Garnett’s research team has generated novel 3D organoid cultures that serve as highly scalable and functional cancer models with the ability to capt
Rigaku Launches Fourth Generation Handheld 1064 nm Raman Analyzer for Chemical Threat Analysis at IAFC HAZMAT 202512.6.2025 16:00:00 CEST | Press release
Revolutionizing Safety & Security Industries: New Technology Enhances Rapid Identification in the Hot Zone Rigaku Analytical Devices, a division under Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami), announces the launch of its fourth generation 1064 nm Raman analyzers - the Icon series, featuring enhancements in chemical threat analysis for safety and security applications. The first in the series, the Icon-X, will be showcased at The International Hazardous Materials Response Teams Conference (HAZMAT), hosted by the International Association of Fire Chiefs (IAFC), in Baltimore, MD USA from June 13-14, 2025. From June 13 onward, we will begin rolling out global sales. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612450341/en/ Icon-X Image The Icon-X is the first 1064 nm Raman analyzer to provide standoff chemical analysis allowing users to analyze potentially dangerous subst
GD32C231 Series MCU — Redefining Cost-Performance, Unleashing New Potential!12.6.2025 15:00:00 CEST | Press release
GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, officially launches the GD32C231 series, a high-performance entry-level microcontroller built on the Arm® Cortex®-M23 core. The GD32C231 new series expands GigaDevice’s MCU portfolio, offering cost-effective solutions for applications such as small home appliances, BMS (Battery Management Systems), small-screen display devices, handheld electronics, industrial auxiliary controls, and automotive aftermarket systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612289779/en/ GD32C231 block diagram With over 2 billion MCUs shipped, GigaDevice leverages its mature supply chain and innovation to push past the limitations of traditional entry-level chips. The GD32C231 microcontroller series brings powerful integration, wide-voltage industrial-grade design, and a complete development ecosystem
Eaton to help power resilient energy future for Hartsfield-Jackson Atlanta International Airport12.6.2025 14:33:00 CEST | Press release
Power system project supports ongoing, $12.8 billion ATLNext airport expansion and modernization initiativeAirport-wide standardization on Eaton Brightlayer digitalization solutions to enhance reliability and streamline maintenance Intelligent power management company Eaton announced today it was awarded multiple contracts valued at approximately $25 million to help Hartsfield-Jackson Atlanta International Airport enhance and expand its electrical infrastructure. Eaton is providing comprehensive engineering services and electrical solutions to support the airport’s broader modernization efforts – establishing a resilient energy backbone with the real-time data and intelligent tools needed to optimize energy efficiency, accommodate future growth and enhance overall performance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612565866/en/ Eaton is supporting the expansion and modernization of Hartsfield-Jackson Atlanta Inte
FlightLogger Lifts Payment Efficiency for Aviation Training Businesseswith BlueSnap12.6.2025 14:30:00 CEST | Press release
Flight training management software FlightLogger leverages BlueSnap’s embedded payments functionality to streamline operations for flight schools and support business growth. BlueSnap, a global payment orchestration platform for leading B2B and B2C businesses, announced its selection by FlightLogger as its international payments partner, unlocking global payments capabilities and greater financial flexibility and acceptance for pilots in training. As a leading flight training management software company, FlightLogger – backed by leading private equity company Arcadea Group – helps 200 flight schools across more than 50 countries optimize their pilot training workflows and operations. It is an all-digital platform that can be used on any device. FlightLogger selected BlueSnap to support its international payments operations and reduce its technical debt, following a recommendation from payment advisory company PayTech Partners. BlueSnap was chosen for its strong international processing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom